Curium Announces the Submission of its Marketing
Submission follows the completion of Phase III PYTHON clinical trial of [18F]-DCFPyL for recurrent prostate cancer in Europe in May 2022 Phase III PYTHON clinical trial results to be presented at the 35th Annual Congress of the European Association of Nuclear Medicine, October 15-19, 2022 in Barcelona, Spain PARIS, June 27, 2022 (GLOBE NEWSWIRE) — … Read more